Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02279 YONGHE MEDICAL
RT Nominal unchange0.750 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others618,551-3.697%642,296450,213309,437231,136
Land & other Lease Assets871,789-11.872%989,235925,142810,653494,985
Intangible Assets35,163-11.379%39,67841,2573,5473,307
Interests in Asso. & JCEs0--0000
Other Non-current Assets109,73257.478%69,68134,05233,10723,352

1,635,235-6.069%1,740,8901,450,6641,156,744752,780
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories76,005-13.718%88,08953,13826,99614,486
Trade Receivables10,26745.528%7,05513,35110,3305,859
Cash & Bank Balances603,2156.746%565,0931,566,192292,85689,789
Other Current Assets119,839-77.356%529,241115,958107,43068,299
Assets Held for Sale0--0000

809,326-31.960%1,189,4781,748,639437,612178,433
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables79,41680.622%43,96836,05944,67622,545
S-T Debt & Leases322,86069.432%190,554259,228172,921141,695
Other Current Liabilities320,62521.455%263,986442,393287,603116,488
Liab asso w/ Assets Held for Sale0--0000

722,90145.013%498,508737,680505,200280,728
Net Current Assets86,425-87.492%690,9701,010,959(67,588)(102,295)
Total Assets Less Current Liabilities1,721,660-29.204%2,431,8602,461,6231,089,156650,485
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases772,693-8.562%845,048762,303682,879411,172
Other Non-current Liabilities6,716347.137%1,502975219193

779,409-7.931%846,550763,278683,098411,365
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital80.000%8800
  Reserves942,549-40.545%1,585,3021,698,337406,058239,120
  Others0--0000
Shareholders' Funds942,557-40.544%1,585,3101,698,345406,058239,120
Non-controlling Interests(306)--0000
Others0--0000

942,251-40.564%1,585,3101,698,345406,058239,120
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments9,252-75.688%38,05579,36277,23221,498
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 25/11/2024 11:57
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -138,572,000
%Change-38.737%
EPS / (LPS)RMB -0.280
NBV Per Share (¥)RMB 1.526
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.